Notice of Intent to Award a Sole Source Contract - Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Place of performance: Liverpool, United Kingdom
Free. Verify your email, then we send one reminder only.
- Posted
- Jul 27, 2026
- Closes
- No deadline published by the funder
At a glance
This is a government contract opportunity posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF in the research and development in biotechnology (except nanobiotechnology) category. Work is performed in Liverpool, United Kingdom.
Classification and identifiers
- Industry (NAICS)
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- Product or service (PSC)
- Health R&D Services; Health Care Services; Experimental Development (AN13)
- Solicitation number
- OC-2026-135667
- Contracting office
- FOOD AND DRUG ADMINISTRATION
Who can apply
About this opportunity
Procurement Type: Sole Source Simplified Acquisition Procedures (SAP) Purchase Order for Commercial Items Authority: FAR Part 6.103-1, Only One Responsible Source Subject: Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak Description: The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price purchase order to The University of Liverpool for the Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak, in accordance with the authority under FAR Part 6.103-1, Only One Responsible Source. This procurement is being conducted under simplified acquisition procedures in accordance with FAR Part 12 (RFO). The NAICS Code for this action is 541714 - Research and Development in Biotechnology (except N...